Angiotensin II and the Cardiac Complications of Diabetes Mellitus

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|13|26|2721-2729

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.13, Iss.26, 2007-09, pp. : 2721-2729

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Angiotensin II blockade may prevent type 2 diabetes mellitus

By  

Inpharma, Vol. 1, Iss. 1511, 2005-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Cardiac Metabolism in Diabetes Mellitus

By  

Current Pharmaceutical Design, Vol. 14, Iss. 25, 2008-09 ,pp. : 2521-2526

Bentham Science Publishers

Access to resources Recommend Favorite

Modulation of metabolic and cardiac dysfunctions by insulin sensitizers and angiotensin receptor blocker in rat model of type 2 diabetes mellitus

By Hussein Abd El-Aziz M.   Omar Nisereen M.   Sakr Hussein   Elsamanoudy Ayman Z.   Shaheen Dalia  

Canadian Journal of Physiology and Pharmacology, Vol. 89, Iss. 3, 2011-03 ,pp. : 216-226

NRC Research Press

Access to resources Recommend Favorite

Optimization of Cardiac Metabolism in Diabetes Mellitus

By  

Current Pharmaceutical Design, Vol. 14, Iss. 25, 2008-09 ,pp. : 2537-2550

Bentham Science Publishers

Access to resources Recommend Favorite

Approaches to Prevention of Cardiovascular Complications and Events in Diabetes Mellitus

By Coccheri Sergio  

Drugs, Vol. 67, Iss. 7, 2007-01 ,pp. : 997-1026

Adis International

Access to resources Recommend Favorite